UBS Group Portfolio holdings
UBS Group is the Swiss bank holding company behind UBS, which was created in 1998 when Union Bank of Switzerland merged with Swiss Bank Corporation; the holding company was listed in New York in 2014. Its business spans wealth management, investment banking, asset management and banking for individuals and companies. Its asset management arm offers stock, bond, currency, hedge fund, real estate, infrastructure and private equity strategies, which can also be combined in multi-asset portfolios. The group's roots go back to the Bank in Winterthur, founded in 1862, and to Swiss Bank Corporation, started by six private bankers in Basel by 1854. The wealth management arm serves high net worth individuals worldwide, and its US business grew out of Paine Webber, the American brokerage UBS merged with in 2000 and renamed UBS Wealth Management USA in 2003. In 2023 UBS took over Credit Suisse in a rescue deal arranged by the Swiss government and central bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.15B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$611M |
| 3 |
SpaceX
SPCX
|
+$567M |
| 4 |
Apple
AAPL
|
+$511M |
| 5 |
Jabil
JBL
|
+$463M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.49B |
| 2 |
Western Digital
WDC
|
+$1.42B |
| 3 |
Lumentum
LITE
|
+$951M |
| 4 |
Intel
INTC
|
+$785M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$749M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.93% |
| 2 | Technology | 18.61% |
| 3 | Financials | 7.85% |
| 4 | Industrials | 6.96% |
| 5 | Healthcare | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5776
Lucid Diagnostics
LUCD
$76M
| $904K | ﹤0.01% |
845,314
+399,835
| +90% | +$431K |
2025 Q1
5 quarters
|
|
5777
Thryv Holdings
THRY
$52.4M
| $904K | ﹤0.01% |
229,544
+74,855
| +48% | +$266K |
2021 Q1
21 quarters
|
|
5778
ProShares Ultra Silver
AGQ
$939M
| $902K | ﹤0.01% |
13,266
+88
| +0.7% | +$9.7K |
2025 Q4
2 quarters
|
|
5779
Lineage Cell Therapeutics
LCTX
$258M
| $900K | ﹤0.01% |
687,051
-683,410
| -50% | -$944K |
2014 Q4
46 quarters
|
|
5780
Ur-Energy
URG
$296M
| $899K | ﹤0.01% |
660,745
-445,035
| -40% | -$726K |
2017 Q4
34 quarters
|
|
5781
Viemed Healthcare
VMD
$346M
| $897K | ﹤0.01% |
78,713
-139,095
| -64% | -$1.38M |
2022 Q3
15 quarters
|
|
5782
Tuya Inc
TUYA
$987M
| $894K | ﹤0.01% |
507,896
+276,136
| +119% | +$602K |
2022 Q4
14 quarters
|
|
5783
CALL
Krystal Biotech
KRYS
$8.92B
| $892K | ﹤0.01% |
+2,400
| New | +$717K |
2026 Q2
0 quarters
|
|
5784
Universal Logistics Holdings
ULH
$715M
| $890K | ﹤0.01% |
60,137
+5,924
| +11% | +$106K |
2021 Q3
19 quarters
|
|
|
BCAR
5785
DELISTED
D. Boral ARC Acquisition I Corp
BCAR
| $887K | ﹤0.01% |
85,000
+84,426
| +14,708% | +$885K |
2025 Q4
2 quarters
|
|
5786
Newsmax Inc
NMAX
$948M
| $887K | ﹤0.01% |
107,070
-1,807
| -2% | -$13K |
2025 Q1
5 quarters
|
|
5787
Bristow Group
VTOL
$1.09B
| $884K | ﹤0.01% |
21,393
+4,423
| +26% | +$198K |
2014 Q4
46 quarters
|
|
5788
CALL
Truist Financial
TFC
$59.2B
| $882K | ﹤0.01% |
17,700
-17,600
| -50% | -$866K |
2024 Q2
8 quarters
|
|
5789
PUT
CenterPoint Energy
CNP
$27B
| $881K | ﹤0.01% |
+20,000
| New | +$857K |
2026 Q2
0 quarters
|
|
5790
enGene Therapeutics
ENGN
$117M
| $881K | ﹤0.01% |
509,087
+496,070
| +3,811% | +$2.02M |
2025 Q4
2 quarters
|
|
5791
Dimensional Emerging Markets Value ETF
DFEV
$2.03B
| $879K | ﹤0.01% |
20,597
+390
| +2% | +$15.9K |
2026 Q1
1 quarter
|
|
5792
CALL
Fervo Energy
FRVO
$2.66B
| $877K | ﹤0.01% |
+30,000
| New | +$1.08M |
2026 Q2
0 quarters
|
|
5793
Perion Network
PERI
$370M
| $874K | ﹤0.01% |
90,018
-1,021
| -1% | -$9.7K |
2020 Q3
23 quarters
|
|
5794
BridgeBio Oncology
BBOT
$164M
| $874K | ﹤0.01% |
114,655
+64,205
| +127% | +$536K |
2024 Q3
7 quarters
|
|
5795
FerroAtlántica
GSM
$478M
| $873K | ﹤0.01% |
274,429
-63,348
| -19% | -$262K |
2020 Q3
23 quarters
|
|
5796
Organogenesis Holdings
ORGO
$105M
| $872K | ﹤0.01% |
358,708
+151,180
| +73% | +$369K |
2019 Q2
28 quarters
|
|
5797
Lennar Class B
LEN.B
$20.7B
| $871K | ﹤0.01% |
9,818
-6,041
| -38% | -$527K |
2014 Q4
46 quarters
|
|
5798
Bowman Consulting
BWMN
| $871K | ﹤0.01% |
29,816
-9,828
| -25% | -$310K |
2022 Q4
14 quarters
|
|
5799
Gladstone Commercial Corp
GOOD
$493M
| $870K | ﹤0.01% |
70,743
-63,514
| -47% | -$791K |
2014 Q4
46 quarters
|
|
5800
Xperi
XPER
$278M
| $869K | ﹤0.01% |
105,588
+52,476
| +99% | +$380K |
2022 Q3
15 quarters
|
|
Similar funds
UBS Group's Q2 2026 Portfolio in Review
As of Q2 2026, UBS Group held 11,684 positions worth $786B, up 18% from $666B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q2 2026 filing shows 1,281 new, 4,217 increased, 4,362 reduced and 1,275 closed positions. Its largest new stake was Honeywell Aerospace: 2,768,136 shares worth $612M. The largest sale was ExxonMobil, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q2 2026 buy was Honeywell Aerospace: 2,768,136 shares worth $612M.
- UBS Group added most to Microsoft in Q2 2026, an estimated $1.15B increase.
- UBS Group's biggest Q2 2026 reduction was ExxonMobil, cutting an estimated $1.49B.
- UBS Group fully exited Hologic in Q2 2026, selling an estimated $385M.
- UBS Group's ten largest holdings make up 13% of its $786B portfolio in Q2 2026.
- UBS Group opened 1,281 new positions and closed 1,275 in Q2 2026.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $786B.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.